Since Sumitomo’s initial investment in Presperse in 2007, Hino has worked to enhance the levels of service and quality by strengthening the organization and expanding its capabilities. He has broadened the sourcing and distribution network and added value through relationships with Sumitomo Corporation group companies such as Cosmotec International Especialidades Ltd. in Brazil and Summit Pharmaceuticals Europe, and with Sumitomo Corporation Japan and Sumitomo Corporation China. Hino will continue to manage those relationships within his new Japan-based role.
Koh Akiyama has been appointed President and CEO, replacing Hino. Akiyama has been serving as Chairman of the Board of Directors for Presperse and is also a board member of Sumitomo Corporation group companies, Cosmotec International Especialidades Ltd. in Brazil and Summit Pharmaceuticals Europe. He brings almost 30 years of experience at Sumitomo Corporation in the chemicals industry, including 10 years business experience while based in New York.
“I am looking forward to meeting our valued customers and supplier partners, and growing Presperse’s new products portfolio,” said Akiyama. “I am committed to ensuring that we provide our customers the highest quality service and products.”